• If you are wondering whether U.S. Physical Therapy shares still offer fair value at around US$83, you are not alone, many investors are asking the same question.
• The stock has had a mixed run, with a 0.6% decline over the last week, a 1.0% decline over the last month, a 5.3% gain year to date and a 6.7% return over the past year, while the 3 year and 5 year returns sit at 8.0% and 20.6% declines respectively.
• Recent news coverage has mainly focused on U.S. Physical Therapy as an established player in outpatient physical therapy and related services. This helps frame how investors think about its prospects and risk profile. This context is important when weighing whether recent share price moves reflect changing expectations for the business or simply shifting sentiment toward healthcare services in general.
• On our valuation checks, U.S. Physical Therapy scores a 3 out of 6 valuation score. This sets up a closer look at how different valuation methods assess the stock and hints at an even richer way to think about value that we will come back to at the end of this article.

Approach 1: U.S. Physical Therapy Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future cash flows and discounting them back to a present value using a required rate of return.

For U.S. Physical Therapy, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $62.7 million. Analysts provide free cash flow estimates out to 2027, with Simply Wall St extending those projections further by using its own assumptions for later years.

The ten year projections show free cash flow figures rising from $75.0 million in 2026 to $118.6 million in 2035, with each year discounted back to today. Combining these discounted cash flows produces an estimated intrinsic value of about $160.41 per share.

Against a current share price around $83, the model implies a 48.2% discount, which indicates that the shares are trading meaningfully below this DCF based estimate.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests U.S. Physical Therapy is undervalued by 48.2%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

Approach 2: U.S. Physical Therapy Price vs Earnings

For a profitable company like U.S. Physical Therapy, the P/E ratio is a useful way to see what investors are currently paying for each dollar of earnings. It ties the share price directly to the bottom line, which is often how the market frames value for established businesses.

What counts as a “normal” or “fair” P/E usually reflects what investors expect for future earnings and how much risk they see in those earnings. Higher expected growth or lower perceived risk can support a higher P/E, while slower growth or higher risk often comes with a lower P/E.

U.S. Physical Therapy currently trades on a P/E of 58.2x, compared with the Healthcare industry average of 23.7x and a peer average of 15.1x. Simply Wall St’s proprietary Fair Ratio for the stock is 27.1x, which is an estimate of what the P/E could be given its earnings growth profile, industry, profit margin, market cap and risk factors. This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for company specific characteristics rather than using one size fits all benchmarks. Since 58.2x is well above the 27.1x Fair Ratio, the multiple based view suggests the shares look expensive on earnings.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your U.S. Physical Therapy Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These are simple stories that you build around U.S. Physical Therapy by linking your view of its future revenue, earnings and margins to a forecast and then to your own fair value. All of this happens within an easy tool on Simply Wall St's Community page that compares that fair value to the current share price, updates automatically as fresh news or earnings arrive, and lets different investors spell out why, for example, one person sees the shares as closer to the US$106.83 analyst consensus fair value while another, more cautious user might set a materially lower figure based on the same risks around reimbursement pressure, labor costs and competition.

Do you think there's more to the story for U.S. Physical Therapy? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.